NM_001452.2:c.13G>A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001452.2(FOXF2):c.13G>A(p.Gly5Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 997,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001452.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXF2 | NM_001452.2 | c.13G>A | p.Gly5Ser | missense_variant | Exon 1 of 2 | ENST00000645481.2 | NP_001443.1 | |
FOXF2-DT | NR_189293.1 | n.458+122C>T | intron_variant | Intron 1 of 2 | ||||
FOXF2-DT | NR_189294.1 | n.69-734C>T | intron_variant | Intron 1 of 2 | ||||
FOXF2-DT | NR_189295.1 | n.68+1032C>T | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000276 AC: 4AN: 145068Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000821 AC: 7AN: 852758Hom.: 0 Cov.: 27 AF XY: 0.00000502 AC XY: 2AN XY: 398114
GnomAD4 genome AF: 0.0000276 AC: 4AN: 145068Hom.: 0 Cov.: 31 AF XY: 0.0000425 AC XY: 3AN XY: 70514
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.13G>A (p.G5S) alteration is located in exon 1 (coding exon 1) of the FOXF2 gene. This alteration results from a G to A substitution at nucleotide position 13, causing the glycine (G) at amino acid position 5 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at